May 25, 2017
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
Harpoon Therapeutics, a new Arix Group Business, has closed a Series B investment round raising $45 million.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Harpoon Therapeutics